Correction to: First Development, Optimization, and Stability Control of a Pediatric Oral Atenolol Formulation

被引：0
|
作者：
Mauro Morri
Patricia Castellano
Darío Leonardi
Silvana Vignaduzzo
机构：
[1] Universidad Nacional de Rosario,Planta piloto de Producción de Medicamentos, Facultad de Ciencias Bioquímicas y Farmacéuticas
[2] Universidad Nacional de Rosario,Área Análisis de Medicamentos, Departamento Química Orgánica, Facultad de Ciencias Bioquímicas y Farmacéuticas
[3] IQUIR-CONICET,Área Técnica Farmacéutica, Departamento Farmacia, Facultad de Ciencias Bioquímicas y Farmacéuticas
[4] Universidad Nacional de Rosario,Facultad de Ciencias Bioquímicas y Farmacéuticas
[5] Universidad Nacional de Rosario,undefined
来源：
AAPS PharmSciTech | 2018年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the INTRODUCTION section, Atenolol is defined in parenthesis as (ATN, Fig. 1.) The correct definition is (ATN). Fig 1 corresponds to the RESULTS section.
引用
收藏
页码：3907 / 3907
相关论文
共 50 条
  • [21] Oral Formulation of Posaconazole in Nanosuspension: Development and Optimization by Design of Experiments Approach
    Gautham, T. V.
    Patel, Rakesh
    Gupta, V. Rama Mohan
    Devi, G. Parimala
    Dharamsi, Abhay
    ASIAN JOURNAL OF PHARMACEUTICS, 2023, 17 (02) : 221 - 231
  • [22] Captopril oral solution for pediatric use: formulation, stability study and palatability assessment in vivo
    Dysarz, Leticia Pereira
    Tavares, Melanie
    Vicosa, Alessandra Lifsitch
    Ribeiro, Mara Fernandes
    de Silva Teixeira, Rafaela Gomes
    Elias, Sabrina Calil
    Mattos da Silva, Marcio Robert
    dos Santos, Elisabete Pereira
    Ricci-Junior, Eduardo
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 58
  • [23] Formulation development and stability testing of oral morphine solution utilizing preformulation approach
    Preechagoon, D
    Sumyai, V
    Tontisirin, K
    Aumpon, S
    Pongjanyakul, T
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2005, 8 (02): : 361 - 369
  • [24] Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization
    Unal, Sedat
    Aktas, Yesim
    Benito, Juan M.
    Bilensoy, Erem
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 584
  • [25] Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform
    Chandrasekaran, Prabagaran
    Kandasamy, Ruckmani
    AAPS PHARMSCITECH, 2017, 18 (06): : 1972 - 1986
  • [26] Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform
    Prabagaran Chandrasekaran
    Ruckmani Kandasamy
    AAPS PharmSciTech, 2017, 18 : 1972 - 1986
  • [27] Formulation design of oral pediatric Acetazolamide suspension: dose uniformity and physico-chemical stability study
    Santovena, Ana
    Suarez-Gonzalez, Javier
    Martin-Rodriguez, Cristina
    Farina, Jose B.
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2017, 22 (02) : 191 - 197
  • [28] Novel lipid based oral formulation of curcumin: Development and optimization by design of experiments approach
    Pawar, Yogesh B.
    Purohit, Hitesh
    Valicherla, Guru Raghavendra
    Munjal, Bhushan
    Lale, Shantanu V.
    Patel, Sarsvatkumar B.
    Bansal, Arvind Kumar
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 436 (1-2) : 617 - 623
  • [29] Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables
    Mostafa, Haitham Fady
    Ibrahim, Mohamed Abbas
    Sakr, Adel
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (02) : 454 - 463
  • [30] Development of an Oral Liquid Formulation of Nicardipine Hydrochloride Compounded with Simple Excipients for the Treatment of Pediatric Hypertension
    Cavelier, Marine
    Gonde, Henri
    Costa, Damien
    Lamoureux, Fabien
    Pereira, Tony
    Buchbinder, Nimrod
    Varin, Remi
    Hervouet, Charles
    PHARMACEUTICS, 2023, 15 (02)
12345